Wound dressing maker Vomaris, Metrex enter exclusive distribution agreement
Vomaris Innovations announced an agreement to have Metrex become the exclusive global commercial partner for distribution of its Procellera Antimicrobial Wound Dressings. The dressings use technology that employs embedded microcell batteries that generate microcurrents to reduce infection risk and enhance healing, Vomaris said.
Metrex is the only company offering a system of solutions designed to address cross-contamination across an entire healthcare facility, Vomaris said in a statement.
"The growing patient population, escalating threat of resistant microbes and demand to minimize risk of HAIs makes the long-term care segment very important to us,” said Vomaris President and CEO Michael Nagel. He called Procellera Technology “a cost effective non-pharmacologic solution.”Under the terms of the distribution agreement, Metrex will have exclusive global distribution rights to Procellera Technology in the long-term care market, while Vomaris will continue in manufacturing and ongoing research and development.